BWAY
BrainsWay Ltd.
NASDAQ · Healthcare · Medical - Devices · IL
$11.08
−0.63%Oct 28, 2026, 12:00 UTC
BrainsWay announced that it will report its third-quarter 2026 financial results and operational highlights before U.S. markets open on November 10, 2026.
Source:Oct 26, 2026, 11:30 UTC
BrainsWay announced that U.S. medical policies covering its Deep TMS treatment for obsessive-compulsive disorder have expanded to cover more than 118 million lives.
Source:Oct 19, 2026, 11:30 UTC
Brainsway Ltd. announced a strategic collaboration with Inland Psychiatry Medical Group to accelerate the application of interventional psychiatry treatments.
Source:Oct 13, 2026, 11:30 UTC
BrainsWay announced that favorable U.S. medical-policy coverage for its SWIFT Accelerated Deep TMS protocol had expanded to cover more than 70 million lives.
Source:Aug 12, 2026, 11:30 UTC
BrainsWay reported second quarter 2026 financial results, with record revenue of $17.1 million, up 35% compared with Q2 2025.
Aug 6, 2026, 04:29 UTC
BrainsWay reported Q1 2026 revenue up 35% year-over-year with a steady 75% gross margin.
Source:Jul 20, 2026, 11:30 UTC
BrainsWay made a strategic investment in Radial Health, Inc.
Source:Jul 16, 2026, 11:30 UTC
BrainsWay announces a minority-stake investment in Sound Minds Behavioral.
Source: